FAM63B expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62470037423645E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.97619698383278E-14 |
Normal-vs-Stage2 |
1.93660000036289E-07 |
Normal-vs-Stage3 |
1.11022302462516E-16 |
Normal-vs-Stage4 |
1.62436730732907E-12 |
Stage1-vs-Stage2 |
5.819200E-01 |
Stage1-vs-Stage3 |
2.34009999999785E-05 |
Stage1-vs-Stage4 |
1.632150E-04 |
Stage2-vs-Stage3 |
2.457800E-02 |
Stage2-vs-Stage4 |
2.394100E-02 |
Stage3-vs-Stage4 |
8.923800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62481139653892E-12 |
Normal-vs-AfricanAmerican |
1.62658775337832E-12 |
Normal-vs-Asian |
1.149990E-02 |
Caucasian-vs-AfricanAmerican |
3.117000E-01 |
Caucasian-vs-Asian |
2.908400E-01 |
AfricanAmerican-vs-Asian |
1.351590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62470037423645E-12 |
Normal-vs-Female |
5.55111512312578E-16 |
Male-vs-Female |
8.857800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.75929962107102E-10 |
Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(61-80Yrs) |
<1E-12 |
Normal-vs-Age(81-100Yrs) |
1.6716628081781E-12 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.778000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.688200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.077000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.492000E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.676120E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.177800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.83000000000866E-05 |
Normal-vs-Grade 2 |
1.6592283103023E-12 |
Normal-vs-Grade 3 |
1.62447832963153E-12 |
Normal-vs-Grade 4 |
<1E-12 |
Grade 1-vs-Grade 2 |
3.047800E-01 |
Grade 1-vs-Grade 3 |
1.993670E-02 |
Grade 1-vs-Grade 4 |
7.81170000000442E-05 |
Grade 2-vs-Grade 3 |
8.121400E-03 |
Grade 2-vs-Grade 4 |
3.46009999985242E-07 |
Grade 3-vs-Grade 4 |
2.877700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.70734562441066E-14 |
Normal-vs-ccB subtype |
1.62447832963153E-12 |
ccA subtype-vs-ccB subtype |
3.941000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62503344114384E-12 |
Normal-vs-N1 |
4.26779999995741E-06 |
N0-vs-N1 |
8.060200E-01 |
|
|